Jim Cramer on Pfizer Inc. (PFE): ‘It’s Too Low To Sell’

Published on 30 Jan 2025 on Insider Monkey · via Yahoo Finance

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are...

Read the rest of the article

Start tracking your investments with Statfolio

This top pharmaceutical stock was a massive winner in the COVID-19 vaccine sweepstakes but has be...

24/7 Wall St · via AOL 1 Feb 2025

We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this...

Insider Monkey · via Yahoo Finance 1 Feb 2025

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a go...

Zacks · via Yahoo Finance 31 Jan 2025

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we a...

Insider Monkey · via Yahoo Finance 30 Jan 2025

So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a ve...

Simply Wall St. · via Yahoo Finance 30 Jan 2025

Regarding the pharmaceutical giant's dividend metrics, AbbVie stock pays a generous 3.85% yield...

The Motley Fool · via AOL 28 Jan 2025

PFE’s Zacks Rank Pfizer currently carries a Zacks Rank #3 (Hold). Pfizer Inc. Price Pfizer Inc....

Zacks · via Yahoo Finance 28 Jan 2025

On Saturday, Pfizer Inc. (NYSE:PFE) revealed results from the Phase 3 BREAKWATER trial evaluating...

Benzinga · via AOL 27 Jan 2025

Pfizer Pfizer was established in 1849 in New York by two German entrepreneurs. This top...

24/7 Wall St · via AOL 27 Jan 2025

For many investors, the main point of stock picking is to generate higher returns than the overal...

Simply Wall St. · via Yahoo Finance 23 Jan 2025